SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director executed a minor, pre-scheduled sale of common stock valued at approximately $12,000.
• Market Impact: Neutral. The transaction is too small to have any market impact.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Tariq Musa
CIK	0001968281
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	116
Price Per Share	$101.46
Total Value	$11,769.36
Shares Owned After	7,993
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$11,769.36
% of Market Cap	<0.0001%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is insignificant relative to Guardant Health's $12.26 billion market capitalization.
• Ownership Concentration: The sale represents a negligible portion (~1.4%) of the director's direct holdings.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is immaterial in both absolute dollar value and as a percentage of the company's market cap. It was also conducted under a pre-arranged 10b5-1 trading plan.

Volume & Sentiment

• Expected Volume Impact: None. The number of shares is too small to affect trading volume.
• Sentiment Indicator: Neutral. This is a routine insider transaction with no signaling power.

Additional Context

Special Circumstances

• The filing indicates this transaction was made pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on a prior date. This means the sale was pre-scheduled and not based on any immediate, non-public information.